Based on gene expression profiling, Sorlie et al. (2001) classified breast cancer into 5 subtypes, namely, luminal A and B tumors, human epidermal growth factor receptor 2 (HER2) over-expressing tumors, basal, and normal-like tumors [6,7]. This evidence concerns the gene ERBB2 and breast cancer.